EAST WINDSOR, N.J. – Aurobindo Pharma USA, Inc has released Brivaracetam Tablets. Brivaracetam Tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
According to IQVIA, U.S. annual sales for Brivaracetam Tablets were approximately $839.7 million for the 12 months ending Dec 2025.
💊 Product Details:
- Strength: 50 mg & 100 mg
📄 Prescribing Information: [Click here]
🔗 For more details on Aurobindo’s Brivaracetam Tablets, visit: [Link]
Aurobindo was among the first-to-file generic suppliers for this product, and as such is entitled to a shared 180-day generic exclusivity period, along with the other first filers.
